International Vaccine Institute donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Wikipedia pagehttps://en.wikipedia.org/wiki/International_Vaccine_Institute

Donation amounts by donor and year for donee International Vaccine Institute

Donor Total 2017 2016 2015 2014 2013 2012 2010 2009 2008 2007 2006
Bill and Melinda Gates Foundation (filter this donee) 103,809,370.03 9,296,925.00 -2,037,763.00 5,532,437.00 7,595,675.00 18,003,642.00 22,781.03 13,130,248.00 16,265,890.00 100,000.00 14,681,007.00 21,218,528.00
Total 103,809,370.03 9,296,925.00 -2,037,763.00 5,532,437.00 7,595,675.00 18,003,642.00 22,781.03 13,130,248.00 16,265,890.00 100,000.00 14,681,007.00 21,218,528.00

Full list of donations in reverse chronological order (61 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation242,254.002017-11-17Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to support discovery, development and delivery of proven life-saving technologies to meet the unmet needs of the world’s poorest populations; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,768,796.002017-11-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the clinical development and licensure of a safe, efficacious, and affordable new typhoid conjugate vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation90,000.002017-11-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support developing country researchers to participate in the 52nd US-Japan Cholera Meeting in Thailand in February 2018.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,850,057.002017-10-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to generate evidence on the severity, complications and long-term sequelae of invasive salmonellosis, including the relevance of carriers in typhoid transmission, and delineate the types of interventions needed to prevent the disease in high risk groups i; Aid type: Project-type interventions. Affected countries: Nigeria|Congo (the democratic republic of the)|Burkina faso|Ethiopia|Ghana|Kenya|Madagascar.
Bill and Melinda Gates Foundation797,519.002017-10-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support Incepta to achieve licensure and to be able to reliably and consistently produce high-quality, low-cost oral cholera vaccine for Bangladesh; Aid type: Project-type interventions. Affected countries: Bangladesh.
Bill and Melinda Gates Foundation-151,701.002017-06-29Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to contribute to the control of enteric diseases in endemic countries by accelerating the pre-clinical, clinical development, licensure and introduction of bivalent enteric fever conjugate vaccine(s); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-3,119,393.002017-06-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build additional evidence to understand where typhoid vaccine is needed in Africa and accelerate its delivery where needed; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Africa.
Bill and Melinda Gates Foundation3,119,393.002017-06-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to generate evidence on the severity, complications and long-term sequelae of invasive salmonellosis, including the relevance of carriers in typhoid transmission, and delineate the types of interventions needed to prevent the disease in high risk groups i; Aid type: Project-type interventions. Affected countries: Nigeria|Congo (the democratic republic of the)|Burkina faso|Ethiopia|Ghana|Kenya|Madagascar.
Bill and Melinda Gates Foundation700,000.002017-01-29Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide capacity building support for International Vaccine Institute to execute its 2015 strategic plan in support of its mission to discover, develop and deliver safe, effective, and affordable vaccines for global health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation85,000.002016-12-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to fund cholera / enteric researchers to attend the 51st US-Japan Cholera Conference that they would otherwise not be able to afford to contribute; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation235,160.002016-11-28Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- To complete funding of a pivotal trial to enable licensure of a domestically supplied oral cholera vaccine for Bangladesh.; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected countries: Bangladesh.
Bill and Melinda Gates Foundation199,080.002016-05-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to help in increasing the availability of Hepatitis E vaccine for use in endemic countries and facilitate its use during Hepatitis E Virus outbreaks; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-3,095,018.002016-04-29Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of cholera vaccines in endemic countries and evaluate their use for the prevention and control of epidemics; Aid type: Project-type interventions. Affected regions: Africa|Asia.
Bill and Melinda Gates Foundation293,564.002016-04-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to contribute to the control of enteric diseases in endemic countries by accelerating the pre-clinical, clinical development, licensure and introduction of bivalent enteric fever conjugate vaccine(s); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-366,917.002016-04-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a bivalent conjugate vaccine against S. Typhi and S. Paratyphi A. Bivalent Typhoid/Paratyphoid Vaccine Development (Accelerated). Investment start date: 8/14/2013 to end date: 8/1/2015. Grantee name: International Vaccine Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation309,260.002016-03-23Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of cholera in endemic and epidemic settings with the use of a single dose regimen of the cholera vaccine developed by International Vaccine Institute (IVI) and recently licensed in India by Shantha Biotechnics; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Asia.
Bill and Melinda Gates Foundation302,108.002016-02-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of dengue in developing countries by accelerating the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and support the development of dengue vaccine candidates; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected countries: Cambodia|Brazil|Colombia|Viet nam|Kenya|Senegal|Thailand|Gabon.
Bill and Melinda Gates Foundation-245,462.002015-12-14Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to strengthen the International Vaccine Institute’s systems and organizational capabilities in order for it to operate more effectively and efficiently, which will maximize its global health impact and help it deliver on its mission; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,282,891.002015-10-23Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide capacity building support for International Vaccine Institute to execute its 2015 strategic plan in support of its mission to discover, develop and deliver safe, effective, and affordable vaccines for global health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-1,330,050.002015-10-13Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to successfully introduce Vi Vaccines in Typhoid-endemic areas of Asia. The Vi-based Vaccines for Asia (VIVA) Initiative. Investment start date: 9/14/2007 to end date: 5/31/2015. Grantee name: International Vaccine Institute; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Pakistan|Indonesia.
Bill and Melinda Gates Foundation3,558,872.002015-09-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to generate evidence on the severity, complications and long-term sequelae of invasive salmonellosis, including the relevance of carriers in typhoid transmission, and delineate the types of interventions needed to prevent the disease in high risk groups i; Aid type: Project-type interventions. Affected countries: Nigeria|Congo (the democratic republic of the)|Burkina faso|Ethiopia|Ghana|Kenya|Madagascar.
Bill and Melinda Gates Foundation-2,292,053.002015-08-27Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to successfully introduce Vi Vaccines in Typhoid-endemic areas of Asia. The Vi-based Vaccines for Asia (VIVA) Initiative. Investment start date: 9/14/2007 to end date: 5/31/2015. Grantee name: International Vaccine Institute; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Pakistan|Indonesia.
Bill and Melinda Gates Foundation158,082.002015-04-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to allow typhoid, scientific, and global health communities access to new information, thereby facilitating an open dialogue on the importance of this and other pathogens in in sub-Sahara Africa and the required interventions needed for their control; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation237,938.002015-04-13Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to ensure that the Oral Cholera Vaccine is available at a low cost. Commercialization Support for low cost Oral Cholera Vaccines (OCV). Investment start date: 4/13/2015 to end date: 10/14/2015. Grantee name: International Vaccine Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,162,219.002015-03-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to improve the International Vaccine Institute's ability to successfully execute program objectives to deliver a long term reduction in global mortality burden; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,961,085.002014-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the clinical development and licensure of a safe, efficacious, and affordable new typhoid conjugate vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,767,845.002014-11-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide technical and project management support for a novel typhoid conjugate vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation866,745.002014-11-11Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build additional evidence to understand where typhoid vaccine is needed in Africa and accelerate its delivery where needed; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Africa.
Bill and Melinda Gates Foundation5,625,353.002014-02-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of cholera in endemic and epidemic settings with the use of a single dose regimen of the cholera vaccine developed by International Vaccine Institute (IVI) and recently licensed in India by Shantha Biotechnics; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Asia.
Bill and Melinda Gates Foundation-3,752,861.002014-02-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of cholera vaccines in endemic countries and evaluate their use for the prevention and control of epidemics; Aid type: Project-type interventions. Affected regions: Africa|Asia.
Bill and Melinda Gates Foundation-1,111,886.002014-02-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of cholera through the deployment of the killed whole cell oral cholera vaccine in endemic and epidemic settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-760,606.002014-02-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support a project, which is part of WHO’s “Pre-emptive use of a cholera vaccine in vulnerable populations at risk” which will determine if vaccines can be utilized as a public health response to protect high-risk populations from cholera; Aid type: Project-type interventions. Affected countries: Tanzania, united republic of.
Bill and Melinda Gates Foundation6,276,664.002013-11-13Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build additional evidence to understand where typhoid vaccine is needed in Africa and accelerate its delivery where needed; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Africa.
Bill and Melinda Gates Foundation4,742,430.002013-11-07Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of dengue in developing countries by accelerating the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and support the development of dengue vaccine candidates; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected countries: Cambodia|Brazil|Colombia|Viet nam|Kenya|Senegal|Thailand|Gabon.
Bill and Melinda Gates Foundation1,211,198.002013-10-25Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to contribute to the control of enteric diseases in endemic countries by accelerating the pre-clinical, clinical development, licensure and introduction of bivalent enteric fever conjugate vaccine(s); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation773,353.002013-08-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a bivalent conjugate vaccine against S. Typhi and S. Paratyphi A. Bivalent Typhoid/Paratyphoid Vaccine Development (Accelerated). Investment start date: 8/14/2013 to end date: 8/1/2015. Grantee name: International Vaccine Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,999,997.002013-03-21Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of dengue in developing countries by accelerating the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and support the development of dengue vaccine candidates; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected countries: Cambodia|Brazil|Colombia|Viet nam|Kenya|Senegal|Thailand|Gabon.
Bill and Melinda Gates Foundation1,000,000.002012-11-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support. General Operating Support. Investment start date: 11/16/2012 to end date: 5/31/2013. Grantee name: International Vaccine Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,232,064.002012-11-06Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to strengthen the International Vaccine Institute’s systems and organizational capabilities in order for it to operate more effectively and efficiently, which will maximize its global health impact and help it deliver on its mission; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation670,546.942012-05-29Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and supporting continued development of new dengue vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Brazil|Colombia|Viet nam|Thailand.
Bill and Melinda Gates Foundation-11,051.332012-05-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of cholera in endemic and epidemic settings with the use of a single dose regimen of the cholera vaccine developed by International Vaccine Institute (IVI) and recently licensed in India by Shantha Biotechnics; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Asia.
Bill and Melinda Gates Foundation-5,319,854.002012-05-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to fund effective and affordable dengue vaccines for children in dengue-endemic areas; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Thailand|Brazil|Colombia|India|Sri lanka|Singapore|Viet nam|Nicaragua.
Bill and Melinda Gates Foundation-2,395.552012-05-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build additional evidence to understand where typhoid vaccine is needed in Africa and accelerate its delivery where needed; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Africa.
Bill and Melinda Gates Foundation-357,302.092012-05-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of cholera vaccines in endemic countries and evaluate their use for the prevention and control of epidemics; Aid type: Project-type interventions. Affected regions: Africa|Asia.
Bill and Melinda Gates Foundation-4,323.782012-05-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify actions necessary to accelerate introduction and uptake of cholera vaccines in high burden endemic regions in India; Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation-295,474.162012-05-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to successfully introduce Vi Vaccines in Typhoid-endemic areas of Asia. The Vi-based Vaccines for Asia (VIVA) Initiative. Investment start date: 9/14/2007 to end date: 5/31/2015. Grantee name: International Vaccine Institute; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Pakistan|Indonesia.
Bill and Melinda Gates Foundation1,110,571.002012-05-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and supporting continued development of new dengue vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Brazil|Colombia|Viet nam|Thailand.
Bill and Melinda Gates Foundation4,664,890.002010-11-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of cholera through the deployment of the killed whole cell oral cholera vaccine in endemic and epidemic settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,342,461.002010-11-21Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support a project, which is part of WHO’s “Pre-emptive use of a cholera vaccine in vulnerable populations at risk” which will determine if vaccines can be utilized as a public health response to protect high-risk populations from cholera; Aid type: Project-type interventions. Affected countries: Tanzania, united republic of.
Bill and Melinda Gates Foundation6,987,482.002010-11-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and supporting continued development of new dengue vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: Brazil|Colombia|Viet nam|Thailand.
Bill and Melinda Gates Foundation35,415.002010-11-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to bring together a panel of global experts to review what is currently known and identify opportunities for action towards reduction of Hepatitis A and E burden in developing country populations; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002010-04-05Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to develop an assay test that binds to tissue-specific cell markers to not only measure the concentration of anti-body secreting cells, but also identify which of those cells are targeted to mucosal tissues; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation7,181,832.002009-11-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to build additional evidence to understand where typhoid vaccine is needed in Africa and accelerate its delivery where needed; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Africa.
Bill and Melinda Gates Foundation1,097,713.002009-11-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify actions necessary to accelerate introduction and uptake of cholera vaccines in high burden endemic regions in India; Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation7,507,377.002009-10-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the burden of cholera in endemic and epidemic settings with the use of a single dose regimen of the cholera vaccine developed by International Vaccine Institute (IVI) and recently licensed in India by Shantha Biotechnics; Aid type: Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO). Affected regions: Asia.
Bill and Melinda Gates Foundation100,000.002009-09-28Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to test the efficacy of administering two approved vaccines directly under the tongue, which could help improve vaccine delivery, compliance, and enhance immunity against a variety of pathogens.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation889,412.002009-07-03Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of cholera vaccines in endemic countries and evaluate their use for the prevention and control of epidemics; Aid type: Project-type interventions. Affected regions: Africa|Asia.
Bill and Melinda Gates Foundation-510,444.002009-05-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop, evaluate, and introduce vaccines against diseases of the most impoverished including cholera, shigellosis, and typhoid; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Mozambique.
Bill and Melinda Gates Foundation100,000.002008-09-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to explore whether green fluorescent protein is endowed with unique immunological properties which could be used to develop a universal fl u vaccine.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation14,681,007.002007-10-05Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to successfully introduce Vi Vaccines in Typhoid-endemic areas of Asia. The Vi-based Vaccines for Asia (VIVA) Initiative. Investment start date: 9/14/2007 to end date: 5/31/2015. Grantee name: International Vaccine Institute; Aid type: Project-type interventions. Affected regions: Asia; affected countries: Pakistan|Indonesia.
Bill and Melinda Gates Foundation21,218,528.002006-05-30Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the introduction of cholera vaccines in endemic countries and evaluate their use for the prevention and control of epidemics; Aid type: Project-type interventions. Affected regions: Africa|Asia.